Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Joshua Santucci

Vascular Neurology Evanston, IL Medical Doctor

NPI 1568959526 CMS profile 11469247

1000 Central St., Suite 880, Evanston, IL 60201

Open in the dashboard

General payments

$4,334

39 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joshua Santucci of Evanston, IL is reported in the CMS Open Payments database as having received $4,334 across 39 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 73rd percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $991 6
2024 General $3,016 30
2023 General $326 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joshua Santucci
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to Joshua Santucci were reported at $991. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year Joshua Santucci Vascular Neurology median Middle half National median
2019 $0 $263 $102–$1,640 $163
2020 $0 $153 $45–$1,000 $114
2021 $0 $261 $100–$1,355 $132
2022 $0 $242 $87–$1,273 $149
2023 $326 $322 $97–$1,266 $160
2024 $3,016 $247 $70–$1,053 $164
2025 $991 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Stryker Corporation $1,933 11 payments
  2. Medtronic, Inc. $1,387 10 payments
  3. Imperative Care, INc $537 8 payments
  4. Route 92 Medical, Inc. $331 3 payments
  5. AstraZeneca Pharmaceuticals LP $66 4 payments
  6. DePuy Synthes Sales Inc. $32 1 payment
  7. Novartis Pharmaceuticals Corporation $31 1 payment
  8. Philips Electronics North America Corporation $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Travel and Lodging $2,368 10 payments
  2. Food and Beverage $1,966 29 payments
Products named General payments · program years 2023–2025
  1. Pipeline $1,147 8 payments
  2. TARGET $705 4 payments
  3. NEUROFORM EZ 3 $669 1 payment
  4. SURPASS EVOLVE $558 6 payments
  5. ZOOM 88-T LARGE DISTAL PLATFORM $537 8 payments
  6. 8F BASE CAMP SHEATH SYSTEM $307 2 payments
  7. ANDEXXA $66 4 payments
  8. N/A $32 1 payment
  9. KESIMPTA $31 1 payment
  10. (5044) MCOT $17 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

41

Median for Neurology: 833

Drug cost

$166

Median for Neurology: $202,670

Branded share of claims

26.8%

Median for Neurology: 25.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Atorvastatin Calcium Generic 18 $82
Clopidogrel Clopidogrel Bisulfate Brand 11 $49
Lisinopril Generic 12 $34

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$16,689

Medicare's payments for the services billed

Medicare patients

123

Average age 74

Services billed

214

61 women, 62 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 54%
Arthritis 54%
Ischemic heart disease 48%
Heart failure 42%
Chronic kidney disease 41%
Atrial fibrillation 40%
Depression 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

39 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record